Skip to content

MEasurement by a Numerical Approach of BREAst Volume

MEasurement by a Numerical Approach of BREAst Volume MENABREA

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03715738
Acronym
MENABREA
Enrollment
30
Registered
2018-10-23
Start date
2019-07-02
Completion date
2023-09-18
Last updated
2024-12-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Asymmetry, 3D

Brief summary

Breast asymmetry is a rare in plastic surgery. In majority of cases, it is idiopathic. In cases that are poorly tolerated physically (vertebral imbalance, posture disorders) or psychologically, the decision to perform breast symmetrization surgery can be made. It is recommended to do this surgery after a slimming treatment if the woman is overweight or after pregnancy that causes a change in the structure and volume of the chest. In fact, the weight variations deteriorate the long-term result. However, this surgical management remains difficult. In fact, the volume to be removed (unilateral breast reduction) to be symmetrized is a function of the volume of the contralateral breast and the preoperative drawings are made while standing. Currently, the evaluation of the volume to be removed remains subjective and is based on the experience of the surgeon. In addition, intraoperatively, this evaluation is also subjective because the patient is lying down which changes the position of the anatomical landmarks: the optimization of the symmetrization is only possible by the eye and the touch. No measuring device is currently used to assess the difference in volume between the 2 breasts and guide the surgeon in the volume (or weight) to remove. It is therefore sometimes necessary to perform a second intervention in case of residual postoperative asymmetry. Primary objective : To study the association between the weight of tissues removed during the intervention and the variation of the breast volume (pre / postoperative) measured by the Créaform® GOPRO 3D digital camera adjusted on the density of the gland measured by electronic palpation (MyotonPRO). Second objective : To study the association between the weight of tissues removed during the procedure and the variation of the breast volume (pre / postoperative) measured by the Créaform® GOPRO 3D digital camera adjusted on the density of the gland estimated by manual palpation (Likert scale from 1 to 5).

Interventions

OTHERarm 1 : Creaform3D + MyotonPRO

After inclusion,are carried out: * estimation of the volume of the breast to be reduced with the 3D digital camera * measurement of breast density by Likert scale and MyotonPRO The volumetric measurement of the breast is performed using the 3D digital camera. The patient is bent forward with hands resting on a chair to be as still as possible over a period of 30 seconds to 1 minute. The 3D digital camera rotates around the breast to capture the volume of the breast. In peroperative, the weight of tissues removed is weighed (in grams). The removed weight is recorded in the observation notebook. In postoperative (4 months), the possible long-term complications related to the intervention (mainly the dissatisfaction of the patient as for the aesthetic result) are collected then a new acquisition of the mammary volume is carried out with the digital camera 3D. Once this measurement is completed, participation in the study is complete.

Sponsors

University Hospital, Angers
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients referred for uni / bilateral breast reduction as part of an indication of surgical management. * Major patients. * Patients affiliated or beneficiaries of a social security scheme * Patients who have signed prior informed consent.

Exclusion criteria

* Protected patients (pregnant, parturient and lactating women, persons deprived of their liberty by an administrative or judicial decision, persons undergoing psychiatric care under duress, minors, adults over the age of 18) legal protection measure or unable to express their consent). * Patients unfit to understand the objectives or instructions of the study. * Patients in an exclusion period relative to another interventional study.

Design outcomes

Primary

MeasureTime frameDescription
association between weight and volume adjusted to the density of the gland measured by electronic palpationone yearTo study the association between the weight of tissues removed during the intervention and the variation of the breast volume (pre / postoperative) measured by the Créaform® GOPRO 3D digital camera adjusted on the density of the gland measured by electronic palpation (MyotonPRO). Primary judgment criterion: Coefficient associated with volume variation in the linear regression model (model 1) explaining weight by volume variation and density measured by electronic palpation.

Secondary

MeasureTime frameDescription
association between weight and volume adjusted to the density of the gland estimated by manual palpationone yearTo study the association between the weight of tissues removed during the procedure and the variation of the breast volume (pre / postoperative) measured by the Créaform® GOPRO 3D digital camera adjusted on the density of the gland estimated by manual palpation (Likert scale from 1 to 5). Secondary judgment criterion 1: Coefficient associated with volume variation in the linear regression model (Model 2) explaining weight by volume variation and estimated density by manual palpation.
comparison of models 1 and 2one yearComparison of models 1 and 2 (estimated density by manual palpation or measured by electronic method), to see if one model is better than the other. Secondary judgment criterion 2: Akaike Criterion

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026